Search results
- Regulatory news (469) Apply Regulatory news filter
- Press releases (241) Apply Press releases filter
- Basic page (60) Apply Basic page filter
- Corporate presentations (28) Apply Corporate presentations filter
- Pipeline (26) Apply Pipeline filter
- Shareholder meeting (24) Apply Shareholder meeting filter
- Team member (22) Apply Team member filter
- Videos (16) Apply Videos filter
- Financial reports (13) Apply Financial reports filter
- Webcasts and audio (13) Apply Webcasts and audio filter
- Analyst (12) Apply Analyst filter
- Event (7) Apply Event filter
- Investor contact (5) Apply Investor contact filter
- Research (3) Apply Research filter
- Financial calendar (1) Apply Financial calendar filter
- Webform (1) Apply Webform filter
Analytical methods
Oxford BioMedica has developed and optimised all the analytics necessary to support product commercialisation.
Vectors with safety features
Oxford BioMedica’s LentiVector® platform is designed to give the highest safety and efficacy.
Automation and robotics
The LentiVector® platform integrates automated systems enabling scalable and cost-effective manufacture of lentiviral vectors.
200L serum-free suspension cell culture
Oxford BioMedica established serum-free suspension production processes to enhance vector output.
Data analytics and artificial intelligence
Oxford BioMedica is introducing Data Analytics and Artificial Intelligence in its systems to improve productivity and product quality
Oxford Biomedica plc preliminary results for the year ended 31 December 2018
Delivery of dual strategy leads to strong financial growth